Sarepta Therapeutics Inc (S1RP34) Share Price

https://investorshub.advfn.com/uimage/uploads/2024/11/27/hcolltrade-error-314217-the-share-quanitty-is-limited.png
Source: https://www.reddit.com/r/fidelityinvestments/comments/1grxuld/comment/ly9voew

FYI. Found this on a subreddit regarding Fidelity restrictions on trade size.

At a bare minimum, I want to see viable proof that they have solved the issue of mass scale production, cost effectively on a quality consistent basis.
Clear and consice viable proof.

I would be ecstatic if they are ready or already putting out product on a regular basis, be i

"Phunware Loss Causation Decision Dismissing The MTD With No Prejudice to Determining Still Longer Term Damage"
Thanks for the info dbing, finally a bit of sunshine may appear.
Same court, same issues, same law firm and the same plaintiff's attorney, Posner, as the NWBO case. Not sure

Big volume into the close, over 12 million. Someone knows something.

Just Wow. Some reason I knew this was coming.

Now we wait to see this strategic move

Going private? Maybe, then why file for extension or even hire an auditor, was this a last minute decision?

Buyout offer on the table? Who knows

Merger

The short whores are out in force tonight.

It seems that capitulation of short interest is imminent....


HOLD..

HOLD....

HOLD .......


NOW !!!!!



https://www.youtube.com/watch?v

Do you think the decision to set this up to transition on Dec 30 was an accident?

https://x.com/hoffmann6383/status/1861618491058491410

Breaking News: Federal Court Allows Second Spoofing Case against Market Maker to Proceed

The Case: Phunware Inc. v. UBS Securities, LLC, 1:23-cv-06426 (SDNY)

Plaintiff: $PHUN
Defendant:

You might not want to lump me in to "everyone." You had shares until today, when you flip flopped again over your fears of tax loss sellers.

Your playbook is cyclical, and predictable. See you in the morning with your amusing bid whacks, because we both know you've saved some.

"On November 20, 2024, Super Micro Computer, Inc. (the “Company”) prepaid in full and terminated its obligations under each of (i) the Loan Agreement, by and among the Company and Cathay Bank, as amended or otherwise modified, and (ii) the Loan and Security Agreement with Bank of America N.A., by an

Another China monster and the clowns missed it as always

KDLY beautiful run

It has been a month and Patrick has been quiet. What does that say for the company performance?

Interesting. The procedural history appears to be a lot different from our case. In PHUN, the defendant’s MTD was granted but the court allowed plaintiff to file a motion to amend their complaint. It seems that in granting this motion, the Court has also allowed the case to speed past another MTD op

Shares updated on OTCM

MTEK next drone play… weekly breaking out.

I do not discount what you said. I knew the field of play was not level. Just like a football field bows in the middle for drainage. Most people know their are sharks in the water.

Yes, I don't have shares, not going to feed into paid pumpers on this board nor dirty hicks. I just like to entertain myself every now and then, IHUB is cheap entertainment, there are some good folks over on this board, Risk and OS are my favorite and a few in between, they have never disrespected

DALE E. HO, United States District Judge:
On April 23, 2024, this Court issued an Opinion and Order dismissing Plaintiff
Phunware, Inc.’s Complaint for failure to adequately plead loss causation. See Opinion and
Order (“Order”) at 13-16, ECF No. 30. The parties’ familiarity with

https://investorshub.advfn.com/uimage/uploads/2024/11/26/tj[[ebtc_111111_26_30d_833pm_CHAN_KEY_W_XRP.jpg

Begging the question : Just WHEN might the 100,000 get revisited ?.....Soon, or could it take a while ?....January 20th ?



Likewise / similarily - Th

He's in your head, not the other way round.

https://investorshub.advfn.com/uimage/uploads/2024/3/7/dgoetDRK.JPG

This will be interesting, but we know that cancer cells are able to develop multiple mechanisms that enable the evasion of NKs. These mechanisms are likely the reason why NK based therapies show only limited success in clinic trials. Here is just one mechanism (that was recently found) https://www.c

Dr. Mike Korenko stated “We are pleased with the FDA’s decision to grant Breakthrough Device Designation following our recent data submissions.